Why the study?
Does invasive hemodynamic monitoring with a pulmonary artery catheter improve survival and guide therapy in patients with cardiogenic shock?
Does invasive hemodynamic monitoring with a pulmonary artery catheter improve survival and guide therapy in patients with cardiogenic shock?
Answers are grounded in this paper and cite their sources.
This viewpoint highlights contemporary observational evidence supporting urgent pulmonary artery catheterization for hemodynamic phenotyping, shock team decision-making, and ventricular assist device selection to reduce mortality in severe cardiogenic shock.
Cardiogenic shock (CS) is defined by the presence of signs and symptoms of low tissue perfusion associated with systolic blood pressure (BP) < 90mmHg, according to the European Society of Cardiology. Within the different types of shock - cardiogenic, distributive, hypovolemic, and mixed - CS is responsible for up to 66% of shock cases in intensive care units and occurs due to poor perfusion secondary to low cardiac output. The most prevalent etiology is ST-elevation myocardial infarction (STEMI); other causes include acute chronic heart failure, valvular diseases, and arrhythmias. 1,2 In-hospital mortality from CS associated with STEMI can reach 36% in cases not associated with a heart attack, 31%. Furthermore, effective treatment is related to understanding the disease mechanism and classifying the patient into phenotypes, which will impact the implemented therapy.
No takes yet. Share an insight, caveat, or question.
Savaris et al. (2023) conducted an editorial in Cardiogenic shock. Pulmonary artery catheterization (right heart catheterization) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: